We are live on ! Find out more

1,062 hedge funds and large institutions have $68.3B invested in Amgen in 2013 Q3 according to their latest regulatory filings, with 95 funds opening new positions, 372 increasing their positions, 430 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 95 | Existing positions closed: 52

19% more funds holding in top 10

Funds holding in top 10: 4857 (+9)

14% more capital invested

Capital invested by funds: $59.9B → $68.3B (+$8.37B)

3% more funds holding

Funds holding: 1,0321,062 (+30)

13% less repeat investments, than reductions

Existing positions increased: 372 | Existing positions reduced: 430

17% less call options, than puts

Call options by funds: $780M | Put options by funds: $936M

Holders
1,062
Holders Change
+30
Holders Change %
+2.91%
% of All Funds
34.42%
Holding in Top 10
57
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+18.75%
% of All Funds
1.85%
New
95
Increased
372
Reduced
430
Closed
52
Calls
$780M
Puts
$936M
Net Calls
-$156M
Net Calls Change
+$150K
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$451M +$84.6M +780,413 +24%
UBS AM
27
UBS AM
Illinois
$394M -$5.61M -51,751 -1%
BA
28
BlackRock Advisors
Delaware
$381M -$5.4M -49,792 -1%
Legal & General Group
29
Legal & General Group
United Kingdom
$381M -$8.75M -80,689 -2%
Morgan Stanley
30
Morgan Stanley
New York
$377M -$13.8M -127,574 -4%
American Century Companies
31
American Century Companies
Missouri
$346M +$12.6M +115,930 +4%
State Farm Mutual Automobile Insurance
32
State Farm Mutual Automobile Insurance
Illinois
$327M
Lazard Asset Management
33
Lazard Asset Management
New York
$319M -$97.7M -901,284 -24%
Goldman Sachs
34
Goldman Sachs
New York
$319M -$8.01M -73,836 -3%
Bank of America
35
Bank of America
North Carolina
$307M -$8.55M -78,817 -3%
Grantham, Mayo, Van Otterloo & Co (GMO)
36
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$299M +$65.3M +602,464 +29%
Axa
37
Axa
France
$298M +$23M +212,356 +9%
Charles Schwab
38
Charles Schwab
California
$297M -$2.85M -26,257 -1%
O
39
OrbiMed
New York
$294M +$1.11M +10,200 +0.4%
VOYA Investment Management
40
VOYA Investment Management
Georgia
$294M -$58.7M -541,598 -17%
Bank of Montreal
41
Bank of Montreal
Ontario, Canada
$289M -$29.3M -270,569 -9%
Fidelity International
42
Fidelity International
Bermuda
$284M +$64.8M +597,883 +31%
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$284M -$13.6M -125,810 -5%
Allianz Asset Management
44
Allianz Asset Management
Germany
$282M -$23.6M -217,739 -8%
HSBC Holdings
45
HSBC Holdings
United Kingdom
$257M +$13.6M +125,090 +6%
BlackRock
46
BlackRock
New York
$254M +$2.27M +20,946 +0.9%
Wells Fargo
47
Wells Fargo
California
$248M -$134M -1,232,550 -36%
Sumitomo Mitsui Trust Group
48
Sumitomo Mitsui Trust Group
Japan
$248M +$6.26M +57,735 +3%
GE
49
General Electric
Ohio
$248M +$77.2M +711,743 +47%
AIM
50
abrdn Investment Management
United Kingdom
$245M +$20.6M +190,312 +10%

AMGN Hedge Fund Activity: Q3 2013 in Review

1,062 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q3 2013, worth a combined $68.3B — up 14% from $59.9B a quarter earlier.

Buyers outnumbered sellers: 95 funds opened new AMGN positions and 52 closed out — a net gain of 43 holders — while 372 added to existing stakes and 430 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $176M. The largest seller was Fidelity Investments, cutting an estimated $261M.

  • 1,062 institutional investors held Amgen (AMGN) as of Q3 2013, up from 1,032 in Q2 2013.
  • Funds reported $68.3B of Amgen stock for Q3 2013, up 14% quarter-over-quarter.
  • 95 funds opened new Amgen positions in Q3 2013 and 52 closed out, a net change of +43 holders.
  • The largest Amgen buyer in Q3 2013 was Adage Capital Partners, an estimated $176M added.
  • The largest Amgen seller in Q3 2013 was Fidelity Investments, an estimated $261M sold.

Based on aggregated 13F filings for Q3 2013.